This is a preview of subscription content, log in via an institution to check access.
References
Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14(9):914–925. https://doi.org/10.1016/S1474-4422(15)00111-8
Fisher M, Schmutzhard E (2017) Posterior reversible encephalopathy syndrome. J Neurol 264(8):1608–1616
Christophe LT, Eric R, Sandrine F (2007) Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST). Ther Clin Risk Manag 3(2):341–348. https://doi.org/10.2147/tcrm.2007.3.2.341
Saraceno L, Ricigliano AGV, Cavalli M, Meola G (2017) Posterior reversible encephalopathy syndrome after long-term treatment with low-dose sunitinib: a case report. Neurol Sci 38:1119–1121. https://doi.org/10.1007/s10072-017-2851-7
Jonathan WS, Bérenger L, Frédérique B-S, Stephan E, Christophe M, Jérôme M (2020) Pazopanib-induced posterior reversible encephalopathy syndrome with possible syndrome of inappropriate secretion of antidiuretic hormone: an incidental or pathophysiological association? Neural Regen Res 15(6):1166–1168. https://doi.org/10.4103/1673-5374.270420
Funding
No commercial organizations had any role in the completion or publication of this study. This article was completed without any external funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Informed consent
The authors certify that they have obtained the appropriate patient consent forms. In the form the patient has given her consent for her images and other clinical information to be reported in the journal.
Reporting statement
This manuscript was prepared in accordance with the CAse REport (CARE) guideline.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rifino, N., Mantero, V., Filizzolo, M.G. et al. Sunitinib associated posterior reversible encephalopathy syndrome in a patient treated for GIST. Acta Neurol Belg 120, 995–997 (2020). https://doi.org/10.1007/s13760-020-01367-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-020-01367-6